Search Results | Cancer Research | American Association for Cancer Research

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Abstract 5344: High-throughput CRISPR-Cas9 knockout screens identify loss of miRNA1304-5p targeting the RAS/MAPK pathway as a modulator of resistance to ALK inhibitors in high-risk neuroblastoma

Perla Pucci, Liam Lee, Suzanne Turner, Leila Jahangiri, Jamie Matthews, Amos Burke, Patrick Reynolds, Lukas Kenner, Olaf Merkel, Fikret Rifatbegovic, Ji Luo, Peter Ambros, MiaoJun Han

Cancer Res (2022) 82 (12_Supplement): 5344.

DOI: https://doi.org/10.1158/1538-7445.AM2022-5344

Published: 15 June 2022

View article

Journal Articles

Abstract I17: Genomic loss of the wild-type KRAS allele in pancreatic tumor progression and metastasis

Han Yan, Chih-Chieh Yu, Stuart Fine, Ayman Lee, Ye-Ran Yang, Juan Yan, Dario Garcia-Carracedo, Dillon Karg, Edwin Cheung, Richard Friedman, Emily Chen, Ji Luo, Yi Miao, Wanglong Qiu, Gloria Su

Cancer Res (2019) 79 (24_Supplement): I17.

DOI: https://doi.org/10.1158/1538-7445.PANCA19-I17

Published: 13 December 2019

View article

Journal Articles

The Achilles Heel of Malignant Rhabdoid Tumors

Jing Huang, Ji Luo

Cancer Res (2019) 79 (11): 2808–2809.

DOI: https://doi.org/10.1158/0008-5472.CAN-19-0990

Published: 03 June 2019

View article

Journal Articles

Genome-Wide RNAi Screen Identifies PMPCB as a Therapeutic Vulnerability in EpCAM⁺ Hepatocellular Carcinoma

Atsushi Takai, Hien Dang, Naoki Oishi, Subreen Khatib, Sean P. Martin, Dana A. Dominguez, Ji Luo, Rachel Bagni, Xiaolin Wu, Katie Powell, Qing-Hai Ye, Hu-Liang Jia, Lun-Xiu Qin, Jinqiu Chen, Gary A. Mitchell, Xiaoling Luo, Snorri S. Thorgeirsson, Xin Wei Wang

Cancer Res (2019) 79 (9): 2379–2391.

DOI: https://doi.org/10.1158/0008-5472.CAN-18-3015

Published: 01 May 2019

View article

Includes: Supplementary data

Journal Articles

Abstract 4388: The role of neoantigens in immunotherapy of cutaneous melanoma

Renee M. Thomas, Chi-Ping Day, Zoe Weaver Ohler, Rajaa El Meskini, Carri Graff-Cherry, Sung Chin, Aleksandra Michalowski, Ji Luo, Terry Van Dyke, Glenn Merlino

Cancer Res (2016) 76 (14_Supplement): 4388.

DOI: https://doi.org/10.1158/1538-7445.AM2016-4388

Published: 15 July 2016

View article

Journal Articles

Abstract IA8: Genetic approaches to cancer

Nicole L. Solimini, Andrea L. Bredemeyer, Mamie Z. Li, Rameen Beroukhim, Matthew Meyerson, Stephen J. Elledge, Natalya N. Pavlova, Qikai Xu, Craig H. Mermel, Anthony C. Liang, Michael R. Schlabach, Ji Luo, Anna E. Burrows, Anthony N. Anselmo

Cancer Res (2012) 72 (13_Supplement): IA8.

DOI: https://doi.org/10.1158/1538-7445.CSB12-IA8

Published: 06 November 2014

View article

Journal Articles

Abstract IA28: Haploinsufficiency in cancer

Teresa Davoli, Nicole L. Solimini, Natalya N. Pavlova, Qikai Xu, Kristen Mengwasser, Laura M. Sack, Anthony C. Liang, Michael R. Schlabach, Ji Luo, Anna E. Burrows, Anthony N. Anselmo, Mamie Z. Li, Stephen J. Elledge

Cancer Res (2013) 73 (19_Supplement): IA28.

DOI: https://doi.org/10.1158/1538-7445.FBCR13-IA28

Published: 15 May 2014

View article

Journal Articles

Abstract LB-94: Nanoparticle-based RNAi therapy for the delivery of personalized siRNA payloads to KRAS-driven tumors.

Tina L. Yuan, Chih-Shia Lee, Christof Fellmann, Cayde Ritchie, Changwoo Lee, Colin Merrifield, Thomas Schluep, Scott W. Lowe, Ji Luo, Frank McCormick

Cancer Res (2013) 73 (8_Supplement): LB-94.

DOI: https://doi.org/10.1158/1538-7445.AM2013-LB-94

Published: 15 April 2013

View article

Journal Articles

Abstract SY25-03: Haploinsufficiency in cancer: When half simply isn't good enough.

Nicole Solimini, Natalya N. Pavlova, Craig Mermel, Qikai Xu, Anna E. Burrows, Ji Luo, Mamie li, Rameen Beroukhim, Matthew Meyerson, Stephen J. Elledge

Cancer Res (2013) 73 (8_Supplement): SY25-03.

DOI: https://doi.org/10.1158/1538-7445.AM2013-SY25-03

Published: 15 April 2013

View article

Journal Articles

Abstract 4468: Cripto-1 elicits innate resistance to EGFR inhibitors in non-small cell lung cancer harboring EGFR-sensitizing mutations.

Kang-Seo Park, Giaccone Giuseppe, Yisong Wang, Trung Pham, Yongwha Moon, Ji Luo, Liam Changwoo Lee, Tetsuya Mitsudomi, Isamu Okamoto, Yasushi Yatabe, Tony Mok, Mark Raffeld, Liqiang Xi, David S. Salomon, Caterina Bianco

Cancer Res (2013) 73 (8_Supplement): 4468.

DOI: https://doi.org/10.1158/1538-7445.AM2013-4468

Published: 15 April 2013

View article

Journal Articles

Abstract 5331: A novel function of p21 in inhibition of epithelial-mesenchymal transition through microRNAs.

Xiao L. Li, Toshifumi Hara, Youngeun Choi, Murugan Subramanian, Princy Francis, Sven Bilke, Robert L. Walker, Marbin Pineda, Yu-an Yang, Ji Luo, Lalage M. Wakefield, Ben H. Park, Thomas Brabletz, Dipanjan Chowdhury, Paul S. Meltzer, Ashish Lal

Cancer Res (2013) 73 (8_Supplement): 5331.

DOI: https://doi.org/10.1158/1538-7445.AM2013-5331

Published: 15 April 2013

View article

Journal Articles

Abstract 2117: Lasonolide A-induced premature chromosome condensation is mediated by the proto-oncogene c-Raf (Raf1).

Yong-Wei Zhang, Rozenn Josse, Arun Ghosh, Ji Luo, Yves Pommier

Cancer Res (2013) 73 (8_Supplement): 2117.

DOI: https://doi.org/10.1158/1538-7445.AM2013-2117

Published: 15 April 2013

View article

Journal Articles

Abstract 3091: A sumoylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis

Cancer Res (2012) 72 (8_Supplement): 3091.

DOI: https://doi.org/10.1158/1538-7445.AM2012-3091

Published: 15 April 2012

View article

Journal Articles

Abstract LB-314: Array comparative genomic hybridization of thymic epithelial tumors identifies loss of CDKN2A as a prognostic factor and BCL2 family members as targets for therapy

Iacopo Petrini, Paolo A. Zucali, Hye Seung Lee, Ji Luo, Keith J. Killian, Paul S. Melzer, Yonghong Wang, Yisong Wang, Giuseppe Giaccone

Cancer Res (2011) 71 (8_Supplement): LB-314.

DOI: https://doi.org/10.1158/1538-7445.AM2011-LB-314

Published: 15 April 2011

View article

Journal Articles

The Phosphoinositide 3-Kinase Regulatory Subunit p85α Can Exert Tumor Suppressor Properties through Negative Regulation of Growth Factor Signaling

Cullen M. Taniguchi, Jonathon Winnay, Tatsuya Kondo, Roderick T. Bronson, Alexander R. Guimaraes, José O. Alemán, Ji Luo, Gregory Stephanopoulos, Ralph Weissleder, Lewis C. Cantley, C. Ronald Kahn

Cancer Res (2010) 70 (13): 5305–5315.

DOI: https://doi.org/10.1158/0008-5472.CAN-09-3399

Published: 30 June 2010

View article

Includes: Supplementary data

Journal Articles

Abstract #LB-112: A genome-wide synthetic lethal RNAi screen identifies multiple genetic dependencies of the Ras oncogene

Ji Luo, Michael Emanuele, Michael Schlabach, Chad Creighton, Thomas Westbrook, Stephen Elledge

Cancer Res (2009) 69 (9_Supplement): LB-112.

Published: 01 May 2009

View article

Journal Articles

Cancer proliferation gene discovery through multiplex shRNA barcode screen

Ji Luo, Michael Schlabach, Guang Hu, Nicole Solimini, Qikai Xu, Mamie Li, Zhenming Zhao, Agata Smogorzewska, Mathew Sowa, Xiaolu Ang, Thomas Westbrook, Anthony Liang, Kenneth Chang, Jennifer Hackett, J. Wade Harper, Gregory Hannon, Stephen Elledge

Cancer Res (2008) 68 (9_Supplement): 936.

Published: 01 May 2008

View article

Journal Articles

Genetic ablation of class IA PI 3-kinase blocks leukemogenesis and uncovers mTOR requirement

Matthew Janes, Michael Kharas, Melanie Matheu, Vanessa Scarfone, Ji Luo, Michael Cahalan, Lewis Cantley, David Fruman

Cancer Res (2007) 67 (9_Supplement): 5716.

Published: 01 May 2007

View article

Journal Articles

Breast cancer-associated mutations in PIK3CA are oncogenic in mammary epithelial cells

Steven J. Isakoff, Jeffrey A. Engelman, Hanna Y. Irie, Rachel V. Pearline, Ji Luo, Saskia M. Brachmann, Lewis C. Cantley, Joan S. Brugge

Cancer Res (2006) 66 (8_Supplement): 345.

Published: 15 April 2006

View article

Journal Articles

Breast Cancer–Associated PIK3CA Mutations Are Oncogenic in Mammary Epithelial Cells

Steven J. Isakoff, Jeffrey A. Engelman, Hanna Y. Irie, Ji Luo, Saskia M. Brachmann, Rachel V. Pearline, Lewis C. Cantley, Joan S. Brugge

Cancer Res (2005) 65 (23): 10992–11000.

DOI: https://doi.org/10.1158/0008-5472.CAN-05-2612

Published: 01 December 2005

View article

NARROW

Abstract 5344: High-throughput CRISPR-Cas9 knockout screens identify loss of miRNA1304-5p targeting the RAS/MAPK pathway as a modulator of resistance to ALK inhibitors in high-risk neuroblastoma

Abstract I17: Genomic loss of the wild-type KRAS allele in pancreatic tumor progression and metastasis

The Achilles Heel of Malignant Rhabdoid Tumors

Genome-Wide RNAi Screen Identifies PMPCB as a Therapeutic Vulnerability in EpCAM⁺ Hepatocellular Carcinoma

Abstract 4388: The role of neoantigens in immunotherapy of cutaneous melanoma

Abstract IA8: Genetic approaches to cancer

Abstract IA28: Haploinsufficiency in cancer

Abstract LB-94: Nanoparticle-based RNAi therapy for the delivery of personalized siRNA payloads to KRAS-driven tumors.

Abstract SY25-03: Haploinsufficiency in cancer: When half simply isn't good enough.

Abstract 4468: Cripto-1 elicits innate resistance to EGFR inhibitors in non-small cell lung cancer harboring EGFR-sensitizing mutations.

Abstract 5331: A novel function of p21 in inhibition of epithelial-mesenchymal transition through microRNAs.

Abstract 2117: Lasonolide A-induced premature chromosome condensation is mediated by the proto-oncogene c-Raf (Raf1).

Abstract 3091: A sumoylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis

Abstract LB-314: Array comparative genomic hybridization of thymic epithelial tumors identifies loss of CDKN2A as a prognostic factor and BCL2 family members as targets for therapy

The Phosphoinositide 3-Kinase Regulatory Subunit p85α Can Exert Tumor Suppressor Properties through Negative Regulation of Growth Factor Signaling

Abstract #LB-112: A genome-wide synthetic lethal RNAi screen identifies multiple genetic dependencies of the Ras oncogene

Cancer proliferation gene discovery through multiplex shRNA barcode screen

Genetic ablation of class IA PI 3-kinase blocks leukemogenesis and uncovers mTOR requirement

Breast cancer-associated mutations in PIK3CA are oncogenic in mammary epithelial cells

Breast Cancer–Associated PIK3CA Mutations Are Oncogenic in Mammary Epithelial Cells

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only